Sort
78,016 grants matching “breast cancer”
Whitlockite nanoparticle-based immunotherapy for bone metastasis
$531,867Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2023 · CA
CARLE CANCER CENTER COMMUNITY CLINICAL ONCOLOGY PROGRAM
$531,860Carle Clinic Association, P C · U10 · FY2000 · CA
Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer
$531,794Leif W Ellisen · Massachusetts General Hospital · R01 · FY2024 · CA
Mechanisms of APOBEC3A-induced cancer evolution and cancer vulnerability
$531,759Michael S Lawrence · Massachusetts General Hospital · R01 · FY2025 · CA
Exploring the dynamic tumor-immune ecosystem of breast cancer in heterogeneous tumor microenvironments
$531,693Stacey Deleria Finley · University Of Southern California · U01 · FY2025 · CA
The role of IWS1 in development and tumorigenesis
$531,687Philip N Tsichlis · Tufts Medical Center · R01 · FY2016 · CA
The role of IWS1 in development and tumorigenesis
$531,687Philip N Tsichlis · Tufts Medical Center · R01 · FY2017 · CA
Pathways that regulate basal and metastatic phenotypes in triple negative breast cancers
$531,677Teresa L Wood · Rbhs-New Jersey Medical School · R01 · FY2017 · CA
HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers
$531,650Douglas F Nixon · George Washington University · R01 · FY2016 · CA
Inhibitors of protein-protein interactions
$531,607Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
$531,560Arti Hurria · Beckman Research Institute/City Of Hope · R01 · FY2011 · AG
Biospecimen Acquisition, Processing and Classification Unit
$531,549Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · U2C · FY2019 · CA
Genetic studies of mammographic density
$531,518Johanna M Rommens · Hospital For Sick Chldrn (Toronto) · R01 · FY2007 · CA
Biomarkers of Molecular Age to Predict the Toxicity of Cancer Chemotherapy
$531,500Hyman B Muss · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers
$531,474Paul Joseph Goodfellow · Ohio State University · R01 · FY2018 · CA
Integrated genomic approaches to identify and validate cancer targets
$531,473William C Hahn · Dana-Farber Cancer Inst · R33 · FY2009 · CA
Career Development in Pediatric and Medical Oncology
$531,466Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2016 · CA
Interpersonal therapy for depression in Breast Cancer
$531,458Carlos Blanco · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2010 · CA
The adaptor protein Crk in immune responses
$531,451Dongfang Liu · Methodist Hospital Research Institute · R56 · FY2017 · AI
Mechanistic Studies of Genetic Recombination
$531,447Stephen Charles Kowalczykowski · University Of California At Davis · R01 · FY2011 · GM
Homologous recombination mechanisms in mammalian cells
$531,434Maria Jasin · Sloan-Kettering Inst Can Research · R35 · FY2017 · GM
Homologous recombination mechanisms in mammalian cells
$531,434Maria Jasin · Sloan-Kettering Inst Can Research · R35 · FY2018 · GM
IDENTIFYING COMPOUNDS FOR TARGETED BREAST CANCER TREATMENT AND PREVENTION
$531,359Temple University-Of The Commonwealth System Of Higher Education · · FY2014 · Department of the Army
MAINLINE HEALTH CCOP
$531,351Lankenau Institute For Medical Research · U10 · FY2002 · CA
OCHSNER COMMUNITY CLINICAL ONCOLOGY PROGRAM
$531,345Ochsner Clinic Foundation · U10 · FY2000 · CA